130 related articles for article (PubMed ID: 2786689)
1. Kinetics of heparin action.
Shore JD; Olson ST; Craig PA; Choay J; Björk I
Ann N Y Acad Sci; 1989; 556():75-80. PubMed ID: 2786689
[No Abstract] [Full Text] [Related]
2. Structure and activity of heparin and its fragments: an overview.
Choay J
Semin Thromb Hemost; 1989 Oct; 15(4):359-64. PubMed ID: 2479102
[No Abstract] [Full Text] [Related]
3. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
Turk B; Brieditis I; Bock SC; Olson ST; Björk I
Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin.
Church FC; Meade JB; Treanor RE; Whinna HC
J Biol Chem; 1989 Feb; 264(6):3618-23. PubMed ID: 2914965
[TBL] [Abstract][Full Text] [Related]
5. Effect of heparin on the inhibition of the contact system enzymes.
Colman RW; Scott CF; Pixley RA; de la Cadena RA
Ann N Y Acad Sci; 1989; 556():95-103. PubMed ID: 2786690
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III-dependent anti-prothrombinase activity of heparin and heparin fragments.
Schoen P; Lindhout T; Willems G; Hemker HC
J Biol Chem; 1989 Jun; 264(17):10002-7. PubMed ID: 2722856
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
Lane DA; Denton J; Flynn AM; Thunberg L; Lindahl U
Biochem J; 1984 Mar; 218(3):725-32. PubMed ID: 6721831
[TBL] [Abstract][Full Text] [Related]
8. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
Baruch D; Lindhout T; Wagenvoord R; Hemker HC
Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
[TBL] [Abstract][Full Text] [Related]
10. A new synthetic pentasaccharide with increased anti-factor Xa activity: possible role for anionic clusters in the interaction of heparin and antithrombin III.
Petitou M; Lormeau JC; Choay J
Semin Thromb Hemost; 1991; 17 Suppl 2():143-6. PubMed ID: 1948084
[No Abstract] [Full Text] [Related]
11. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of heparin action.
Jackson CM
Baillieres Clin Haematol; 1990 Jul; 3(3):483-504. PubMed ID: 2176902
[TBL] [Abstract][Full Text] [Related]
13. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
Huntington JA; Gettins PG
Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
[TBL] [Abstract][Full Text] [Related]
14. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
15. Practical considerations on the measurement of low molecular weight heparin anti-Xa activity.
Aiach M; Roncato M
Semin Thromb Hemost; 1985 Apr; 11(2):108-11. PubMed ID: 4035362
[No Abstract] [Full Text] [Related]
16. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
Ofosu FA; Fernandez F; Gauthier D; Buchanan MR
Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370
[No Abstract] [Full Text] [Related]
17. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
Pletcher CH; Cunningham M; Nelsestuen GL
Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
Tran TH; Bondeli C; Marbet GA; Duckert F
Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
[TBL] [Abstract][Full Text] [Related]
19. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of esterase and amidase activities of alpha- and beta-thrombin in the presence of antithrombin III and heparin.
Borsodi A; Machovich R
Biochim Biophys Acta; 1979 Feb; 566(2):385-9. PubMed ID: 570423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
